Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Origin and Therapies of Osteosarcoma
Brice Moukengué, Morgane Lallier, Louise Marchandet, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3503-3503
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Current Status and Prospects of Targeted Therapy for Osteosarcoma
Zunguo Hu, Shuang Wen, Zijun Huo, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3507-3507
Open Access | Times Cited: 55
Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods
Barbara L.F. Kaplan, Alan M. Hoberman, William Slikker, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 2, pp. 251-266
Open Access | Times Cited: 9
Prognostic and Therapeutic Significance of Cancer‐Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single‐Cell RNA Sequencing Data
Yukang Que, Ti Ding, Huming Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Hybrid membranes-mediated biomimetic-nanoparticle carrying miR-665 for effective tumor treatment by remodeling tumor microenvironment
Bo Zhang, Chengqi Zhang, Chen Cao, et al.
International Journal of Pharmaceutics (2025), pp. 125479-125479
Closed Access
Bibliometric analysis of autophagy in the diagnosis and treatment of osteosarcoma: a bibliometric analysis (2007–2023)
Min Zhu, Wei Xiang, Zhoujun Zhu, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Composing On-Program Triggers and On-Demand Stimuli into Biosensor Drug Carriers in Drug Delivery Systems for Programmable Arthritis Therapy
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Azizi Miskon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1330-1330
Open Access | Times Cited: 18
Bone Healing via Carvacrol and Curcumin Nanoparticle on 3D Printed Scaffolds
Aditi Dahiya, Vishal Sharad Chaudhari, Susmita Bose
Small (2024)
Open Access | Times Cited: 3
Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling
Sara F.F. Almeida, Liliana Santos, Gabriela Sampaio-Ribeiro, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model
Alayna N. Hay, Khan Mohammad Imran, Alissa Hendricks-Wenger, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2737-2737
Open Access | Times Cited: 7
Repurposing the diuretic benzamil as an anti-osteosarcoma agent that acts by suppressing integrin/FAK/STAT3 signalling and compromising mitochondrial function
Meng-Chieh Lin, Guan-Yu Chen, Hsin‐Hsien Yu, et al.
Bone and Joint Research (2024) Vol. 13, Iss. 4, pp. 157-168
Open Access | Times Cited: 2
The Role of Ubiquitination in Osteosarcoma Development and Therapies
Peng Mao, Zuxi Feng, Yongxin Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 791-791
Open Access | Times Cited: 2
Zn-Doped Calcium Magnesium Phosphate Bone Cement Based on Struvite and Its Antibacterial Properties
П. А. Крохичева, M. A. Goldberg, А. С. Фомин, et al.
Materials (2023) Vol. 16, Iss. 13, pp. 4824-4824
Open Access | Times Cited: 5
Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma
Renxian Wang, Dingding Wang, Xueshan Bai, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Relationship between tumorigenesis, metastasis, immune evasion, and chemoresistance in osteosarcoma therapy
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Mainul Haque, et al.
Journal of Applied Pharmaceutical Science (2023)
Open Access | Times Cited: 5
The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma
Zexin Su, Chenyang Wang, Runsang Pan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Zn-Doped Calcium Magnesium Phosphate Bone Cements Based on Struvite and Their Antibacterial Properties
П. А. Крохичева, M. A. Goldberg, А. С. Фомин, et al.
(2023)
Open Access | Times Cited: 4
Co-delivery of curcumin and si-STAT3 with a bioinspired tumor homing for polydopamine nanoparticles for synergistic osteosarcoma therapy
Kun-Zhe Wu, Zhongsheng Zhou, Te Liu, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
An “organic-inorganic” hybrid multilayer film for comprehensive support in soft and hard tissue regeneration after osteosarcoma resection
Qian Tang, Zhe Liu, Zhichao Hu, et al.
Materials Today Advances (2023) Vol. 20, pp. 100444-100444
Open Access | Times Cited: 4
Identification of TNFRSF1A as a potential biomarker for osteosarcoma
Yuke Zhang, Kai Liu, Jianzhong Wang
Cancer Biomarkers (2024) Vol. 39, Iss. 4, pp. 299-312
Open Access | Times Cited: 1
Oligopeptide modified ICG/Cisplatin@CaCO3 for targeted osteosarcoma NIR-II imaging guided multimodal therapy
Lichen Ji, Jiaqing Huang, Xu-gang Zhong, et al.
Materials & Design (2024) Vol. 242, pp. 112965-112965
Open Access | Times Cited: 1
Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy
Nele Prasse, Charlotte Wessolowski, Ingo Müller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5344-5344
Open Access | Times Cited: 1
FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation
He Zhang, Yang Bai, Jiatong Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 1
Diagnostic value of combined detection of AKP, TSGF, and LDH for pediatric osteosarcoma: a case-control study
Tao Sun, Jin Ma, Shumin Zhu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 8, pp. 3667-3677
Open Access | Times Cited: 1
Integrated immunogenomic analyses of single-cell and bulk profiling construct a T cell-related signature for predicting prognosis and treatment response in osteosarcoma
Chicheng Niu, Weiwei Wang, Qingyuan Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma
Safiya Khurshid, Akila S. Venkataramany, Matías Montes, et al.
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200908-200908
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top